Gard Frodahl Tveitevåg Svingen
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Gard Frodahl Tveitevåg Svingen has a total of 23 co-authors. Here are the top co-authors by number of shared publications:
- Dennis Winston Trygve Nilsen
Department of Cardiology, Stavanger University Hospital, 4068 Stavanger, Norway
2 shared publications - Elin Strand
Department of Clinical Science, University of Bergen, Bergen, Norway
2 shared publications - Eva Ringdal Pedersen
Department of Heart Disease, Haukeland University Hospital, Bergen, Norway
2 shared publications - Ottar Nygård
Haukeland University Hospital, Department of Heart Disease, Bergen, Norway
2 shared publications - Per Magne Ueland
Bevital AS, Bergen, Norway
2 shared publications - Bodil Bjørndal
Department of Clinical Science, University of Bergen, 5020 Bergen, Norway
1 shared publication
Latest Publications
- Open Access
- 14 January 2025
- Published by Elsevier in American Journal of Preventive Cardiology
- Vol. 21, 100932
Elevated plasma trimethyllysine is associated with incident atrial fibrillation
- 14 January 2025
- Published by Elsevier in American Journal of Preventive Cardiology
- Vol. 21, 100932
Open AccessElevated plasma trimethyllysine is associated with incident atrial fibrillation
- Open Access
- 23 August 2016
- Published by Norwegian Medical Association in Tidsskrift for Den norske legeforening
Kolinholdige metabolitter i relasjon til livsstilssykdommer
Legelivet - Kolinholdige metabolitter er forbundet med økt risiko for hjerteinfarkt, diabetes og død.
- 23 August 2016
- Published by Norwegian Medical Association in Tidsskrift for Den norske legeforening
Open AccessKolinholdige metabolitter i relasjon til livsstilssykdommer
Legelivet - Kolinholdige metabolitter er forbundet med økt risiko for hjerteinfarkt, diabetes og død.
- Open Access
Peroxisome Proliferator-Activated Receptor Activation is Associated with Altered Plasma One-Carbon Metabolites and B-Vitamin Status in Rats
Plasma concentrations of metabolites along the choline oxidation pathway have been linked to increased risk of major lifestyle diseases, and peroxisome proliferator-activated receptors (PPARs) have been suggested to be involved in the regulation of key enzymes along this pathway. In this study, we investigated the effect of PPAR activation on circulating and urinary one-carbon metabolites as well as markers of B-vitamin status. Male Wistar rats (n = 20) received for 50 weeks either a high-fat control diet or a high-fat diet with tetradecylthioacetic acid (TTA), a modified fatty acid and pan-PPAR agonist with high affinity towards PPARα. Hepatic gene expression of PPARα, PPARβ/δ and the enzymes involved in the choline oxidation pathway were analyzed and concentrations of metabolites were analyzed in plasma and urine. TTA treatment altered most biomarkers, and the largest effect sizes were observed for plasma concentrations of dimethylglycine, nicotinamide, methylnicotinamide, methylmalonic acid and pyridoxal, which were all higher in the TTA group (all p < 0.01). Hepatic Pparα mRNA was increased after TTA treatment, but genes of the choline oxidation pathway were not affected. Long-term TTA treatment was associated with pronounced alterations on the plasma and urinary concentrations of metabolites related to one-carbon metabolism and B-vitamin status in rats.
Open AccessPeroxisome Proliferator-Activated Receptor Activation is Associated with Altered Plasma One-Carbon Metabolites and B-Vitamin Status in Rats
Plasma concentrations of metabolites along the choline oxidation pathway have been linked to increased risk of major lifestyle diseases, and peroxisome proliferator-activated receptors (PPARs) have been suggested to be involved in the regulation of key enzymes along this pathway. In this study, we investigated the effect of PPAR activation on circulating and urinary one-carbon metabolites as well as markers of B-vitamin status. Male Wistar rats (n = 20) received for 50 weeks either a high-fat control diet or a high-fat diet with tetradecylthioacetic acid (TTA), a modified fatty acid and pan-PPAR agonist with high affinity towards PPARα. Hepatic gene expression of PPARα, PPARβ/δ and the enzymes involved in the choline oxidation pathway were analyzed and concentrations of metabolites were analyzed in plasma and urine. TTA treatment altered most biomarkers, and the largest effect sizes were observed for plasma concentrations of dimethylglycine, nicotinamide, methylnicotinamide, methylmalonic acid and pyridoxal, which were all higher in the TTA group (all p < 0.01). Hepatic Pparα mRNA was increased after TTA treatment, but genes of the choline oxidation pathway were not affected. Long-term TTA treatment was associated with pronounced alterations on the plasma and urinary concentrations of metabolites related to one-carbon metabolism and B-vitamin status in rats.
- Open Access
- 1 May 2015
- Published by Elsevier in Atherosclerosis
- Vol. 240 (1) , 115-120
Glycated hemoglobin and long-term prognosis in patients with suspected stable angina pectoris without diabetes mellitus: A prospective cohort study
- 1 May 2015
- Published by Elsevier in Atherosclerosis
- Vol. 240 (1) , 115-120
Open AccessGlycated hemoglobin and long-term prognosis in patients with suspected stable angina pectoris without diabetes mellitus: A prospective cohort study